Eagle Pharmaceuticals
50 Tice Blvd, Suite 315
Woodcliffe Lake
New Jersey
07677
United States
Tel: (201) 326-5300
Website: https://www.eagleus.com/
290 articles about Eagle Pharmaceuticals
-
Eagle Pharma Release: Company Completes NDA Submission For Ryanodex For Exertional Heat Stroke To FDA
1/23/2017
-
Eagle Pharma’ Pemetrexed NDA Submitted For Review
1/3/2017
-
Eagle Pharma Announces David Pernock As President And Chief Commercial Officer
12/19/2016
-
Eagle Pharma Reports Positive Results From Pivotal Animal Study Supporting The Efficacy Of RYANODEX For Exertional Heat Stroke
12/13/2016
-
Eagle Pharma Snaps Up Massachusetts' Arsia in $78 Million Deal
11/11/2016
-
Eagle Pharma Reports Third Quarter 2016 Results
11/9/2016
-
Eagle Pharma And Teva Release: Centers for Medicare & Medicaid Services Establishes Unique J-Code For BENDEKA (Bendamustine Hydrochloride) Injection
11/2/2016
-
Eagle Pharma Announces Positive Initial Results Of Animal Study Exploring Use Of Ryanodex In MDMA (Ecstasy) Induced Hyperthermia Conducted At NIH
10/31/2016
-
Eagle Pharma To Discuss Third Quarter 2016 Financial Results On November 9, 2016
10/27/2016
-
Eagle Pharma Announces “Save The Date” For 2016 Investor Day
9/28/2016
-
Eagle Pharma Reports Second Quarter 2016 Results
8/9/2016
-
Eagle Pharma Reports Positive Outcome From FDA Meeting For RYANODEX For Exertional Heat Stroke NDA Submission
8/9/2016
-
Eagle Pharma To Discuss Second Quarter 2016 Financial Results On August 9, 2016
7/26/2016
-
Eagle Pharma Announces Changes To Its Board Of Directors; Director, Michael Graves Appointed Chairman
7/5/2016
-
Eagle Pharma Founder, President & CEO Scott Tarriff Named EY Entrepreneur Of The Year 2016 New Jersey Region
6/27/2016
-
Eagle Pharma To Present At Upcoming June Conferences
5/31/2016
-
Eagle Pharma Reports First Quarter 2016 Results; Bendeka Achieves 71% Total Market Share
5/9/2016
-
Eagle Pharma To Present At May Conferences
4/27/2016
-
Eagle Pharma To Discuss First Quarter 2016 Financial Results On May 9, 2016
4/25/2016
-
Eagle Pharma Release: CMS Determines that Existing J-Code J9033 Adequately Describes BENDEKA (bendamustine hydrochloride) Injection
4/20/2016